药品的价格和销售量反应出药品对人类生命健康和疾病治愈的价值,作为二者的共同体现,药品的销售额从一个侧面反应出了药品对于治疗人类疾病所产生的贡献。本文盘点2015年全球销售额最高的10种药物,其中有4种自身免疫性疾病治疗药物、2种糖尿病药物、1种慢性丙肝药物、2种抗肿瘤药物、1种疫苗,这从一定程度上能够窥见目前对人类各大疾病领域贡献最为突出的药物。
[1] FirstWord lists: The 100 best selling pharmaceutical brands[EB/OL].2016-04-18.http://www.firstwordpharma.com/node/1375342#axzz4Ac06kjsg.
[2] 了解TNF拮抗剂[EB/OL].[2016-05-30].http://www.yisaipu.com/AboutYsp.
[3] Package insert HUMIRA (adalimumab) Abbott laboratories[EB/OL].2002-12-31.http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/adalabb123102LB.htm1/27/2003.
[4] 修美乐进入中国5年全球适应证达13个[EB/OL].2016-01-13.http://health.gmw.cn/2016-01/13/content_18485379.htm.
[5] 百亿超级重磅药物更替辉瑞和艾伯维大PK[EB/OL].2014-04-14.http://news.bioon.com/article/6647424.html.
[6] 知名调研机构发布2016畅销药预测修美乐居榜首[EB/OL].2016-01-20.http://www.qhnews.com/newscenter/system/2016/01/20/011917616.shtml.
[7] 2016面临专利悬崖的重磅药物Top 5国内申报情况如何[N].医药经济报, 2016-01-06.
[8] 恩利[EB/OL].[2016-05-05].http://enbrel.dxy.cn.
[9] 2014年全球畅销药Top50及国产竞品分析[N].医药经济报, 2015-10-23.
[10] Remicade infliximab[EB/OL].1998-08-24.http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/inflcen082498lb.pdf.
[11] 关于类克的重要资料[EB/OL].2007-09-01.http://www.xian-janssen.com.cn/RemiCARE/faq/faq01.asp.
[12] 西安杨森肿瘤坏死因子抑制剂类克在华上市[EB/OL].2007-09-03.http://health.sohu.com/20070903/n251928078.shtml.
[13] 默沙东重磅单抗类克市场惨遭生物仿制药侵蚀, 西格列汀暂守一城[EB/OL].2015-10-30.http://www.bioon.com/industry/mdnews/615540.shtml.
[14] Rituximab formulated bulk product approval information-Licensing action[EB/OL].1997-11-26.http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm093352.htm.
[15] 美罗华专利即将到期新药Gazyva将成最佳替代[EB/OL].2014-09-02.http://www.qianzhan.com/analyst/detail/220/140902-a0cc5b56.html.
[16] 糖尿病新药机会最活跃国内药企研发方向在哪[N].医药经济报, 2015-7-10.
[17] LANTUS[EB/OL].2000-04-20.http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21081lbl.pdf.
[18] 赛诺菲庆祝来得时R中国上市10周年[N].北京晨报, 2014-09-10.
[19] 2015年十大专利到期药物[EB/OL].2014-12-21.http://yao.dxy.cn/article/95666?trace=hot.
[20] JANUVIA(sitagliptin phosphate) Tablets[EB/OL].2006-10-16.http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021995lbl.pdf.
[21] 糖尿病新药捷诺达上市[EB/OL].2013-01-25.http://health.sohu.com/20130125/n364613117.shtml.
[22] 田恬.2015年药物研发热点回眸[J].科技导报, 2016, 34(1): 57-64.
[23] 癌症[EB/OL].2015-02.http://www.who.int/mediacentre/factsheets/fs297/zh/.
[24] AVASTIN (Bevacizumab)[EB/OL].2004-02-26.http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/125085lbl.pdf.
[25] 安维汀肺癌适应症正式在中国上市[EB/OL].2015-08-03.http://care.39.net/a/150803/4669191.html.
[26] 复星医药单克隆抗体新药获药品临床试验批准[EB/OL].2016-05-30.http://www.fosunpharma.com/news/news-details-2600.html.
[27] HERCEPTIN® Trastuzumab[EB/OL].1998-09-25.http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/trasgen092598lb.pdf.
[28] 专注十年呵护新生[EB/OL].2012-04-09.http://www.roche.com.cn/medias/news/pharma-news/25.html.
[29] 罗氏新药Kadcyla有望弥补赫赛汀专利悬崖[EB/OL].2013-08-04.http://www.bioon.com/industry/internation/578584.shtml.
[30] 哈维尼Harvoni-人类彻底攻克丙肝已不远[EB/OL].2015-10-09.http://mt.sohu.com/20151009/n422811344.shtml.
[31] HARVONITM (ledipasvir and sofosbuvir) tablets[EB/OL].2014-10-10.http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205834s000lbl.pdf.
[32] 2016年世界免疫周: 弥合免疫差距[EB/OL].2016-04-24.http://www.who.int/campaigns/immunization-week/2016/event/zh/.
[33] Pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) [EB/OL].2000-02-17.http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094057.htm
